Your search returned 65 studies:
- Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity - Cardiovascular Complications
Location: Nashville, Tennessee
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity - Cardiovascular Complications
Location: Nashville, Tennessee
- Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
Conditions: Arthralgia - Breast Cancer
Location: Nashville, Tennessee
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Conditions: ErbB2 Overexpressing - Solid Tumors - Metastatic Breast Cancer - Neoplasms, Breast
Location: Nashville, Tennessee
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Castration-Resistant Prostate Cancer - Hormone Receptor-Positive Breast Cancer - Ewing's Family of Sarcomas
Location: Nashville, Tennessee
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
Location: Nashville, Tennessee
- Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Conditions: Lung Cancer - Non Small Cell Lung Cancer (NSCLC) - Breast Cancer - ER+ Breast Cancer
Location: Nashville, Tennessee
- Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Conditions: Solid Tumors - Neoplasms, Breast - Cancer
Location: Nashville, Tennessee
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed
Conditions: Metastatic Breast Cancer - Trastuzumab - BKM120 - HER2+
Location: Nashville, Tennessee
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
Location: Nashville, Tennessee
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
Location: Nashville, Tennessee
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Conditions: Advanced Solid Tumors With an Alteration of the PIK3CA Gene - Estrogen Receptor Positive Breast Cancer
Location: Nashville, Tennessee
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
Location: Nashville, Tennessee
- NBRST: Prospective Neo-adjuvant REGISTRY Trial
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Conditions: Metastatic Solid Tumor - Breast Cancer - Ovarian Cancer
Location: Nashville, Tennessee
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Nashville, Tennessee
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Nashville, Tennessee
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Nashville, Tennessee
- A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
Conditions: Locally Advanced HER2-Negative Breast Cancer
Location: Nashville, Tennessee
- Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-06
Conditions: Breast Neoplasms
Location: Nashville, Tennessee
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study of LY3023414 in Participants With Advanced Cancer
Conditions: Advanced Cancer - Metastatic Cancer - Lymphoma - Metastatic Breast Cancer - Malignant Mesothelioma
Location: Nashville, Tennessee
- Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Plac
Conditions: Metastatic Breast Cancer
Location: Nashville, Tennessee
- Phase 2 Study of the Monoclonal Antibody MGAH22(Margetuximab)in Patients With Relapsed or Refractory Advanced Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity - Cardiovascular Complications
Location: Nashville, Tennessee
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity - Cardiovascular Complications
Location: Nashville, Tennessee
- Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
Conditions: Arthralgia - Breast Cancer
Location: Nashville, Tennessee
- Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
Location: Nashville, Tennessee
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Gestational Trophoblastic Tumor - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Ovarian C
Location: Nashville, Tennessee
- Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Conditions: Advanced Solid Tumors With an Alteration of the PIK3CA Gene - Estrogen Receptor Positive Breast Cancer
Location: Nashville, Tennessee
- Positron Emission Tomography (PET)-Computed Tomography (CT) PET/CT Evaluation of Treatment Response in Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Nashville, Tennessee
- Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: Nashville, Tennessee
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metasta
Conditions: Breast Cancer
Location: Nashville, Tennessee
|